COMPARISON OF FLUCONAZOLE AND KETOCONAZOLE FOR OROPHARYNGEAL CANDIDIASIS IN AIDS

[1]  F. Odds,et al.  Effects of azole antifungals in vitro on host/parasite interactions relevant to Candida infections. , 1988, The Journal of antimicrobial chemotherapy.

[2]  E. Straus,et al.  Gastropathy and ketoconazole malabsorption in the acquired immunodeficiency syndrome (AIDS). , 1988, Annals of internal medicine.

[3]  W. Dismukes.  Azole antifungal drugs: old and new. , 1988, Annals of internal medicine.

[4]  A. Glatt,et al.  Treatment of Infections Associated with Human Immunodeficiency Virus , 1988 .

[5]  D. Hanger,et al.  Fluconazole and testosterone: in vivo and in vitro studies , 1988, Antimicrobial Agents and Chemotherapy.

[6]  J. Barone,et al.  Effect of food and gastric acidity on absorption of orally administered ketoconazole. , 1988, Clinical pharmacy.

[7]  W. Byrne,et al.  Cryptococcal meningitis in the acquired immunodeficiency syndrome (AIDS): successful treatment with fluconazole after failure of amphotericin B. , 1988, Annals of internal medicine.

[8]  M. Saag,et al.  Azole antifungal agents: emphasis on new triazoles , 1988, Antimicrobial Agents and Chemotherapy.

[9]  R. Selik,et al.  Opportunistic diseases reported in AIDS patients: frequencies, associations, and trends. , 1987, AIDS.

[10]  B. Dupont,et al.  Cryptococcal meningitis and fluconazole. , 1987, Annals of internal medicine.

[11]  S. Sherlock,et al.  Hepatic reactions associated with ketoconazole in the United Kingdom. , 1987, British medical journal.

[12]  F. Odds,et al.  Antifungal effects of fluconazole (UK 49858), a new triazole antifungal, in vitro. , 1986, The Journal of antimicrobial chemotherapy.

[13]  J. Galgiani,et al.  Activity of fluconazole (UK 49,858) and ketoconazole against Candida albicans in vitro and in vivo , 1986, Antimicrobial Agents and Chemotherapy.

[14]  J. Raufman,et al.  Ketoconazole-resistant Candida esophagitis in patients with acquired immunodeficiency syndrome. , 1986, Gastroenterology.

[15]  P. Troke,et al.  Efficacy of UK-49,858 (fluconazole) against Candida albicans experimental infections in mice , 1985, Antimicrobial Agents and Chemotherapy.

[16]  M J Humphrey,et al.  Pharmacokinetic evaluation of UK-49,858, a metabolically stable triazole antifungal drug, in animals and humans , 1985, Antimicrobial Agents and Chemotherapy.

[17]  R. Santen,et al.  Site of action of low dose ketoconazole on androgen biosynthesis in men. , 1983, The Journal of clinical endocrinology and metabolism.

[18]  D. Feldman,et al.  Ketoconazole blocks adrenal steroidogenesis by inhibiting cytochrome P450-dependent enzymes. , 1983, The Journal of clinical investigation.

[19]  D. Stevens,et al.  Ketoconazole blocks adrenal steroid synthesis. , 1982, Annals of internal medicine.